Lifecore Biomedical, Inc. De (LFCR) Price to Sales (2010 - 2025)

Lifecore Biomedical has reported Price to Sales for 16 years, with the latest figure at 3.48 in Q2 2025.

• On a quarterly basis, Price to Sales fell 23.35% year-over-year to 3.48 in Q2 2025; TTM through May 2025 was 1.52, a 13.28% increase from a year earlier, with the FY2025 full-year figure at 1.93, up 44.18% from the prior year.
• Price to Sales was 3.48 for Q2 2025 at Lifecore Biomedical, down from 5.91 in the prior quarter.
• The five-year high for Price to Sales was 14.34 in Q3 2021, with the low at 3.48 in Q2 2025.
• Average Price to Sales over 5 years is 8.74, with a median of 8.06 recorded in 2024.
• The sharpest annual moves came in 2021 and 2024: Price to Sales soared 430.27% in 2021, then sank 41.35% in 2024.
• Over 5 years, Price to Sales stood at 9.98 in 2021, then climbed by 16.17% to 11.6 in 2022, then slumped by 34.59% to 7.59 in 2023, then grew by 9.42% to 8.3 in 2024, then tumbled by 58.14% to 3.48 in 2025.
• The last three Price to Sales figures came in at 3.48 (Q2 2025), 5.91 (Q1 2025), and 8.3 (Q4 2024), per Business Quant data.